NCT04380870 is a clinical trial of Chinese Herbal Medicine in Coronavirus Infection, sponsored by Center for Integrated Care.

Who is sponsoring NCT04380870?

NCT04380870 is sponsored by Center for Integrated Care.

What drugs are being tested in NCT04380870?

Interventions in NCT04380870: Chinese Herbal Medicine.

What condition does NCT04380870 study?

NCT04380870 studies Coronavirus Infection.

Is NCT04380870 still recruiting?

NCT04380870 is currently status unknown. Last updated 28 September 2021.

Last reviewed 2021-09-28 · How we verify

NCT04380870

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19

Status unknown Last updated 28 September 2021

What this trial tests

trial testing Chinese Herbal Medicine in Coronavirus Infection in 500 participants. Status unknown.

Timeline

11 May 2020

Primary endpoint
11 December 2021

11 May 2025

Quick facts

Lead sponsor	Center for Integrated Care
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	11 May 2020
Primary completion	11 December 2021
Estimated completion	11 May 2025
Sites	1 location across United States

Drugs / interventions tested

Chinese Herbal Medicine

Conditions studied

Coronavirus Infection — all drugs for Coronavirus Infection →

Sponsor

Center for Integrated Care

Who can join

Adults 18 to 114, any sex, with Coronavirus Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

A Comprehensive Summary of the Knowledge on COVID-19 Treatment.
Peng Y, Tao H, Satyanarayanan SK, Jin K, et al · · 2021 · cited 18× · PMID 33532135 · DOI 10.14336/ad.2020.1124
Plant Bioactives in the Treatment of Inflammation of Skeletal Muscles: A Molecular Perspective.
Karati D, Varghese R, Mahadik KR, Sharma R, et al · · 2022 · cited 9× · PMID 35911155 · DOI 10.1155/2022/4295802
COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2.
Deshmukh R, Harwansh RK, Garg A, Mishra S, et al · · 2024 · cited 5× · PMID 38751601 · DOI 10.2174/0113892029291098240129113500
SEAttle-based Research of Chinese Herbs for COVID-19 Study: A Whole Health Perspective on Chinese Herbal Medicine for Symptoms that may be Related to COVID-19.
Taylor-Swanson L, Altschuler D, Taromina K, Anderson B, et al · · 2022 · cited 3× · PMID 35096490 · DOI 10.1177/21649561211070483
Chinese Herbal Medicine Telehealth Outcomes for Symptoms Possibly Related to COVID-19
Taylor-Swanson L, Taromina K, Mitchell C, Altschuler D, et al · · 2021
Describing Chinese herbal medicine telehealth care for symptoms related to infectious diseases such as COVID-19: a prospective, longitudinal, descriptive cohort study
Taylor-Swanson L, Rubin L, Taromina K, Mitchell C, et al · · 2020

Verify or expand the search:

Other trials of Chinese Herbal Medicine

Trials testing the same drug.

NCT06315101 — Effectiveness and Safety of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellul · completed

Other recruiting trials for Coronavirus Infection

Currently open trials in the same condition.

NCT04885504 — Post COVID-19 Biorepository · recruiting
NCT04445454 — Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection · Phase 1, PHASE2 · recruiting
NCT04510025 — Capturing MultiORgan Effects of COVID-19 · recruiting
NCT04376034 — Convalescent Plasma Collection and Treatment in Pediatrics and Adults · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04380870 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Center for Integrated Care
Last refreshed: 28 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04380870.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing